Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Neil A. Cross"'
Autor:
Sophie M. Pearce, Neil A. Cross, David P. Smith, Malcolm R. Clench, Lucy E. Flint, Gregory Hamm, Richard Goodwin, James I. Langridge, Emmanuelle Claude, Laura M. Cole
Publikováno v:
Metabolites, Vol 14, Iss 6, p 315 (2024)
A multimodal mass spectrometry imaging (MSI) approach was used to investigate the chemotherapy drug-induced response of a Multicellular Tumour Spheroid (MCTS) 3D cell culture model of osteosarcoma (OS). The work addresses the critical demand for enha
Externí odkaz:
https://doaj.org/article/33234cee908948bdb3d0d0201de8eb8b
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-17 (2022)
Abstract Apigenin is a dietary polyphenol found abundantly in fruit and vegetables, which sensitizes leukaemia cells to topoisomerase inhibitor agents (e.g., etoposide), and alkylating agents (e.g., cyclophosphamide), reducing ATP levels and inducing
Externí odkaz:
https://doaj.org/article/950da4487cd14bb28249f4c7439a4817
Publikováno v:
Microorganisms, Vol 11, Iss 3, p 606 (2023)
Porphyromonas gingivalis contributes to the chronic oral disease periodontitis, triggering the activation of host inflammatory responses, inducing cellular stresses such as oxidation. During stress, host cells can activate the Integrated Stress Respo
Externí odkaz:
https://doaj.org/article/8f57dbf9c1cd4545a53a5f5f7acdd7af
Autor:
Lucy E. Flint, Gregory Hamm, Joseph D. Ready, Stephanie Ling, Catherine J. Duckett, Neil A. Cross, Laura M. Cole, David P. Smith, Richard J. A. Goodwin, Malcolm R. Clench
Publikováno v:
Metabolites, Vol 11, Iss 8, p 506 (2021)
Osteosarcoma (OS) is the most common primary bone malignancy and largely effects adolescents and young adults, with 60% of patients under the age of 25. There are multiple cell models of OS described in vitro that express the specific genetic alterat
Externí odkaz:
https://doaj.org/article/f2726bcdd41a49d6a1aeac6eff90899a
Autor:
Chryso Kanthou, David T. Shima, Christiana Ruhrberg, Constantino C. Reyes-Aldasoro, Vivien E. Prise, Katie L. Pettyjohn, Christopher R. Ireson, Davina J. Honess, Sally A. Hill, Sheila Harris, Olga Greco, Meit A. Björndahl, Paul R. Barber, Neil A. Cross, Simon Akerman, Gillian M. Tozer
Tubulin-binding vascular-disrupting agents (VDA) are currently in clinical trials for cancer therapy but the factors that influence tumor susceptibility to these agents are poorly understood. We evaluated the consequences of modifying tumor vascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3745bce3f0ca1db34c63327f4bd3020
https://doi.org/10.1158/0008-5472.c.6497358
https://doi.org/10.1158/0008-5472.c.6497358
Autor:
Chryso Kanthou, David T. Shima, Christiana Ruhrberg, Constantino C. Reyes-Aldasoro, Vivien E. Prise, Katie L. Pettyjohn, Christopher R. Ireson, Davina J. Honess, Sally A. Hill, Sheila Harris, Olga Greco, Meit A. Björndahl, Paul R. Barber, Neil A. Cross, Simon Akerman, Gillian M. Tozer
Supplementary Figure 3 from Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform–Producing Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a706e8b54d26d33b3f3323e0b57458f
https://doi.org/10.1158/0008-5472.22374201
https://doi.org/10.1158/0008-5472.22374201
Autor:
Chryso Kanthou, David T. Shima, Christiana Ruhrberg, Constantino C. Reyes-Aldasoro, Vivien E. Prise, Katie L. Pettyjohn, Christopher R. Ireson, Davina J. Honess, Sally A. Hill, Sheila Harris, Olga Greco, Meit A. Björndahl, Paul R. Barber, Neil A. Cross, Simon Akerman, Gillian M. Tozer
Supplementary Table 1 from Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform–Producing Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17568414d5437adf640620ea76b76e1d
https://doi.org/10.1158/0008-5472.22374180.v1
https://doi.org/10.1158/0008-5472.22374180.v1
Autor:
Chryso Kanthou, David T. Shima, Christiana Ruhrberg, Constantino C. Reyes-Aldasoro, Vivien E. Prise, Katie L. Pettyjohn, Christopher R. Ireson, Davina J. Honess, Sally A. Hill, Sheila Harris, Olga Greco, Meit A. Björndahl, Paul R. Barber, Neil A. Cross, Simon Akerman, Gillian M. Tozer
Supplementary Figure 4 from Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform–Producing Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194c5adf6d517df0a0262094de16bd42
https://doi.org/10.1158/0008-5472.22374198.v1
https://doi.org/10.1158/0008-5472.22374198.v1
Autor:
Chryso Kanthou, David T. Shima, Christiana Ruhrberg, Constantino C. Reyes-Aldasoro, Vivien E. Prise, Katie L. Pettyjohn, Christopher R. Ireson, Davina J. Honess, Sally A. Hill, Sheila Harris, Olga Greco, Meit A. Björndahl, Paul R. Barber, Neil A. Cross, Simon Akerman, Gillian M. Tozer
Supplementary Figure 5 from Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform–Producing Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4562c1d12d15216dc4a4f408f69310
https://doi.org/10.1158/0008-5472.22374195
https://doi.org/10.1158/0008-5472.22374195
Autor:
Chryso Kanthou, David T. Shima, Christiana Ruhrberg, Constantino C. Reyes-Aldasoro, Vivien E. Prise, Katie L. Pettyjohn, Christopher R. Ireson, Davina J. Honess, Sally A. Hill, Sheila Harris, Olga Greco, Meit A. Björndahl, Paul R. Barber, Neil A. Cross, Simon Akerman, Gillian M. Tozer
Supplementary Figure 2 from Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform–Producing Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8caa24adb9e889361b9e4081a255a79c
https://doi.org/10.1158/0008-5472.22374207.v1
https://doi.org/10.1158/0008-5472.22374207.v1